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2Abstract
Amyloid disorders cause debilitating illnesses through the formation of toxic protein aggregates. The
mechanisms of amyloid toxicity and the nature of species responsible for mediating cellular
G\VIXQFWLRQ UHPDLQXQFOHDU+HUHXVLQJȕ2PLFURJOREXOLQ ȕ2m) as a model system, we show that
the disruption of membranes by amyloid fibrils is caused by the molecular shedding of membrane-
active oligomers in a process that is dependent on pH. Using thioflavin T (ThT) fluorescence, NMR,
EM and fluorescence correlation spectroscopy (FCS), we show that fibril disassembly at pH 6.4
results in the formation of non-native spherical oligomers that disrupt synthetic membranes. By
contrast, fibril dissociation at pH 7.4 results in the formation of non-toxic, native monomers.
Chemical cross-linking or interaction with hsp70 increases the kinetic stability of fibrils and
decreases their capacity to cause membrane disruption and cellular dysfunction. The results
demonstrate how pH can modulate the deleterious effects of pre-formed amyloid aggregates and
suggest why endocytic trafficking through acidic compartments may be a key factor in amyloid
disease.
3Significance
Oligomers formed en route to amyloid fibrils are thought to be the perpetrators of toxicity in many
DP\ORLGGLVRUGHUV+RZDP\ORLGILEULOVFRQWULEXWHWRGLVHDVHKRZHYHULVOHVVFOHDU+HUHXVLQJȕ2-
PLFRJOREXOLQ ȕ2m) as a model system, we show that the stability of amyloid fibrils is highly pH-
dependent, with mild acidification enhancing the formation of fibril-derived non-native oligomers that
disrupt membranes and alter cellular function. Enhancing fibril stability by incubation with the
molecular chaperone, hsp70, or by cross-linking, protects against fibril-induced membrane
disruption and cellular dysfunction. The results highlight the importance of pH in determining fibril
stability and suggest that uptake of fibrils into acidic cellular compartments may contribute to
amyloid disease by pH-induced molecular shedding of toxic species.
4\body
Introduction
Amyloid assembly involves the formation of an ensemble of aggregate species that lead to the
onset of pathological cascades and disease (1). The formation of amyloid is initiated by self-
association of partially unfolded or intrinsically disordered precursors which stimulates the
production of an array of oligomeric assembly intermediates. These species, which precede the
formation of mature amyloid fibrils, are commonly described as the agents of toxicity in amyloid
disease (1). The ephemeral nature of oligomeric species, combined with their heterogeneity and co-
population with other species, provides immense challenges for characterising amyloid assembly
intermediates in structural detail and determining their role(s) in fibril assembly (1). It also highlights
the difficulty in identifying which species amongst the aggregate ensemble contributes to cellular
dysfunction and the onset of amyloid disease.
Although oligomers formed from many different proteins have been shown to be toxic (2), the role
that fibrils play in amyloid disease is not well understood. Mounting evidence suggests that fibrils
can be toxic (3–5), or may contribute to disease by acting as reservoirs of toxic oligomers (6). Fibrils
may also contribute to disease by catalysing the formation of oligomers on their surface via
secondary nucleation processes (7), or by disrupting protein homeostasis by consuming the
capacity of the proteostatic network through the sequestration of molecular chaperones (8).
Reduced fibril length can also contribute to disease by increasing the uptake of fibrils into
intracellular compartments (9–11), or by enhancing transmission of aggregation between cells in
prion-like processes (12). In addition, fibrils have been shown to interact with lipid bilayers, causing
membrane deformations via interactions with fibril ends (10, 13, 14), or promoting the release of
toxic oligomers by membrane-induced fibril disassembly (15). Together these data support a role of
amyloid fibrils as direct or indirect agents of amyloid disease.
Since amyloid formation is under kinetic control, minor changes in the population of an amyloid
precursor can lead to dramatic changes in the rate of fibril formation and in the repertoire of
5oligomeric species formed (16, 17). Conversely, the kinetic stability of amyloid fibrils can be
enhanced by alterations in the protein sequence (18), or by adding small molecules (19, 20) or
molecular chaperones (21). Such enhancements in fibril stability can protect against toxicity,
presumably by supressing the formation of oligomers. In addition, fibrils may encounter
environments in vivo that are distinct from those which promote their formation; yet how localised
cellular environments affect the dynamic equilibrium of amyloid fibrils remains unclear.
Here, using amyloid fibrils formed in vitro IURP ȕ2PLFURJOREXOLQ ȕ2m) as a model system, we
explore the effect of altering pH on fibril stability and in determining the nature of the soluble
products that result from fibril disassembly. Using biochemical, biophysical and cellular assays, we
VKRZWKDWȕ2m fibril disassembly is highly sensitive to changes in pH, with a reduction in pH from 7.4
to 6.4 (similar to the difference in pHs encountered early during endocytic trafficking) resulting in
dramatically different outcomes of disassembly. The results reveal how subtle changes in pH can
alter the delicate kinetic balance of intermediates in fibrillation reactions and suggest that increasing
fibril stability, and/or decreasing fibril uptake into acidic cellular compartments, may be a viable
strategy to alleviate the progression of amyloid disease.
Results
pH dependent fibril dynamics
To investigate how pH alters the stability and dynamic behaviour of amyloid fibrils, E2m monomers
were assembled into amyloid fibrils by incubation at acidic pH (Methods). These fibrils have been
analysed structurally in detail and have been shown to possess the canonical parallel in-register E-
VKHHWDP\ORLGVWUXFWXUHIRUPHGE\PDQ\SURWHLQVDQGSHSWLGHVLQFOXGLQJȕ2m fibrils isolated ex vivo
  ,Q DGGLWLRQ ȕ2m fibrils formed under acidic conditions are structurally similar to those
formed in vitro DWQHDUQHXWUDOS+IURPWKH1WHUPLQDOO\WUXQFDWHGȕ2PYDULDQWǻ17KH\DOVR
display similar effects (internalisation into the endo-lysosomal pathway and the inhibition of cellular
reduction of MTT) when incubated with cell lines and with primary cells relevant to the pathology of
ȕ2m dialysis-related amyloidosis (DRA) (monocytes, chondrocytes and osteoblasts) (10, 11, 24, 25).
Moreover, fibrils formed from '1 EXW VHHGHG ZLWK ZLOGW\SH ȕ2m fibrils formed at low pH, have
6been shown to inhibit osteoclast formation from primary human monocytes, hence rationalizing the
osteoarticular pathology associated with DRA (24).
The kinetic stability of the E2m fibrils was measured by diluting fibrils formed at acidic pH into buffer
at pH 7.4 or 6.4 (at an identical ionic strength of 164 mM (Methods)). pH values of 7.4 and 6.4 were
chosen to mimic the environments encountered by fibrils in the extracellular milieu and in early
endosomes, respectively. In previous experiments we have shown that E2m fibrils are taken up into
endosomes and lysosomes in a length-dependent manner, wherein they persist as protease-
resistant material that retains a cross-E structure and results in the perturbation of lysosome function
(11, 24, 25). pH-induced changes in fibril yield and conformation were monitored by ThT
fluorescence and SDS PAGE (Methods). Dilution into each buffer resulted in an initial increase in
ThT fluorescence, presumably due to alterations in ThT binding sites in the fibril-bound state (26),
followed by a slow phase in which the fluorescence intensity decreases (Fig. 1A,B). Fitting to a
double exponential revealed that the rate constants for the enhancement and decay of fluorescence
are similar at both pH values (Fig. S1A-D). Most strikingly, however, the amplitude of the second
phase of the reaction is larger at pH 7.4 than 6.4 (corresponding to 94 % and 55 % at each pH,
respectively). At both pH values, SDS-PAGE analysis of soluble material revealed that the rate of
loss of ThT fluorescence mirrors the rate at which soluble material is formed (Fig. 1A,B). Analysis of
the fibril length distributions using AFM 30 and 60 min after sample dilution at pH 7.4 or 6.4,
respectively, (at which times ca. 25 % soluble material is formed (Fig. 1A,B)), showed a reduction in
fibril length upon incubation at both pH values (Fig. S1E,F). Similar effects were not observed upon
diluting fibrils into growth buffer at pH 2.0 (Fig. S1G). Moreover, mutation of each of the three His
residues known to reside within the core of E2m fibrils (22) significantly decreased the pH
dependency of the loss of ThT fluorescence (Fig. S2), suggesting the protonation state of these His
residues plays a role in determining the extent of pH-dependent fibril disassembly leading to the
formation of soluble material.
7The mechanism of fibril depolymerisation is pH-dependent
To determine the nature of soluble species released during fibril disassembly, fibril depolymerisation
was monitored at pH 6.4 and 7.4 using 1H-15N NMR and the appearance of resonances was
monitored in real time (Figs. 2A,B and S3). Most resonances that were detected have a chemical
shift identical to those of the native protein, enabling the rate of production of native species to be
determined at each pH (Fig. 2C,D). The results revealed that at each pH native amide resonances
LQFUHDVHLQLQWHQVLW\DWDVLPLODUUDWHDFURVVWKHVHTXHQFHRIȕ2m (Fig. 2C,D). However the average
rate of appearance of native resonances is dependent on the pH. The average per-residue time
constant (WIRUWKHDSSHDUDQFHRIQDWLYHȕ2m resonances at pH 7.4 (105 ± 7 min) mirrors Ĳ for the
decay in ThT fluorescence (95 ± 5 min) (Fig. 2C), indicating that fibril disassembly leads to the
IRUPDWLRQ RI QDWLYH ȕ2m monomers. At pH 6.4, by contrast, although the decrease in ThT
fluorescence (99 ± 6 min) occurs at a similar rate to the appearance of soluble material (Fig. 1B),
WKHDSSHDUDQFHRIQDWLYHȕ2m resonances measured using NMR is delayed significantly (171 ± 10
min, Fig. 2D). This suggests that fibril disassembly at pH 6.4 results in the formation of NMR-
invisible species that precede the development of native and unfolded monomers. Indeed, weak
resonances with chemical shifts distinct from those of the native monomer are detected early during
fibril depolymerisation at pH 6.4, but not at pH 7.4 (Fig. S4), suggesting that the ‘NMR invisible’
species are non-native, but not unfolded. The absence of a detectable lag in the appearance of the
native resonances at pH 6.4 suggests that the NMR invisible non-native species could be off-
pathway. Alternatively, an on-pathway model in which the exchange rate for oligomer formation
does not exceed significantly the rate of monomer formation would also fit the data. More
experimental data will be needed to resolve this issue. Irrespective of the kinetic model for their
formation, however, the results show that reducing the pH by a single unit alters the kinetics, and/or
kinetic mechanism, of fibril disassembly such that non-native species accumulate only at the lower
pH.
Oligomeric species accumulate during fibril disassembly at pH 6.4
To characterise and compare the soluble species that form during fibril disassembly in more detail
8fluorescence correlation spectroscopy (FCS) was used. FCS exploits fluctuations in fluorescent
signals as molecules diffuse through a confocal volume of known size (see SI for more detail).
Given its ability to detect species that differ in size over several orders of magnitude, in complex
ensembles and without purification, FCS is an ideal technique to identify and track the ensemble of
species that form during amyloid assembly/disassembly over time.
Fibril depolymerisation was measured using FCS by labelling the E2m variant R3C with maleimide-
Alexa488 (R3C488) (Methods). Residue 3 was chosen as the site to incorporate a fluorescent label
as the N-terminal six residues of E2m do not form part of the fibril core (27). R3C488 was
incorporated into fibrils by seeded elongation in the presence of a 1000-fold molar excess of wild-
type E2m monomers. Fibril depolymerisation was then initiated by diluting these samples into pH 7.4
or 6.4 buffer. Autocorrelation curves (ACs) were acquired immediately and over the course of
depolymerisation (Methods and SI text) (Figs. S5 and S6). The curves were fitted using a maximum
entropy method (MEM) (28) to extract the apparent hydrodynamic radius (RH) of soluble species
released from fibrils during depolymerisation (see SI text for details).
The FCS analysis revealed that soluble species released over the course of fibril depolymerisation
at pH 7.4 are dominated by a low molecular weight species with an apparent RH of 1.9 nm (Fig. 3A,
left panels), equivalent to the apparent RH GHWHUPLQHG IRU QDWLYH ȕ2m monomers (Fig. S7). By
contrast, at pH 6.4 a second species with an apparent RH of 20 nm is highly populated and persists
up to 135 min after the initiation of disassembly (Fig. 3A, right panels). Fitting the ACs to simpler
one or two component functions confirmed that this larger species is only populated significantly
during fibril disassembly at pH 6.4 (Fig. S8, Tables S1 and S2). Analysis of samples 30 min (pH 7.4)
or 60 min (pH 6.4) after initiating depolymerisation using negative stain TEM (Fig. 3B,C) revealed
the presence of spherical oligomers at pH 6.4, but not at pH 7.4. These species range in diameter
from 30-60 nm, measured using cryo-EM (Fig. 3D-E, Fig. S9). Previous studies have shown that
oligomers of this size do not accumulate during fibril formation of 'N6 at pH 6.2 or from wild-type
E2m at pH 2.0, and thus their accumulation is a unique consequence of fibril disassembly at pH 6.4
9(17, 29). Further structural characterisation revealed that these species are not recognised by the
DQWLERG\:2 ZKLFK UHFRJQLVHV WKH FURVVȕ IROGRI DP\ORLG  )LJ$DQG6,0HWKRGVDQG
give rise to a far UV CD spectrum consistent with significant non-native (more highly unfolded)
structure (Fig 4C). By contrast, CD analysis of the soluble species released at pH 7.4 is consistent
with the formation of predominantly native species (Fig. 4B). The oligomers formed at pH 6.4 also
expose greater hydrophobic surface area than those at pH 7.4, measured by the fluorescence of the
hydrophobic dye, 8-anilinonaphthalene-1-sulphonate (ANS) (Fig. 4D,E). Together, the results
indicate that pH alters the energy landscape of fibril depolymerisation such that non-native,
spherical oligomers only become highly, and persistently, populated at pH 6.4.
Fibril-released oligomers cause membrane disruption
The ability of oligomers produced during fibril disassembly at pH 6.4 to disrupt membranes was next
examined by an in vitro dye release assay using large unilamellar vesicles (LUVs) containing 12
mol% bismonoacylphosphate (BMP). BMP is enriched in endosomal/lysosomal membranes and has
been shown previously to sensitise LUVs to disruption by E2m amyloid fibrils (13). The disruption of
BMP-containing membranes by E2m fibrils is also pH dependent, with a large increase in the extent
of membrane disruption observed when the pH is decreased from 7.4 to 6.4 (13). To determine the
extent of membrane disruption caused by soluble species released during fibril depolymerisation,
E2m fibrils were allowed to depolymerise for 60 min at pH 6.4. Filtration was then used to separate
soluble species from fibrillar material, so that the effect of each fraction on membrane integrity could
be assessed individually. These experiments showed that the soluble material released from fibrils
accounts for ca. 70 % of the membrane disruption activity of the total (fibril + soluble) sample (Fig.
5A). Determining the dye release efficiency per µM protein showed that the soluble material is ca. 5-
WLPHVPRUHPHPEUDQHDFWLYHWKDQWKHVDPHPRQRPHUHTXLYDOHQWFRQFHQWUDWLRQRIȕ2m fibrils (Fig.
5B). As native E2m monomers cause minimal dye release (Fig. 5A,B), non-native oligomers that
accumulate during fibril disassembly at pH 6.4 must be responsible for the majority of fibril-mediated
membrane disruption.
10
Restricting molecular shedding decreases membrane damage and fibril-mediated cellular
dysfunction
To determine whether fibril-induced membrane damage can be inhibited by enhancing the kinetic
VWDELOLW\RIȕ2m amyloid fibrils, the molecular chaperone hsp70 was added. Previous studies have
shown that the association of hsp70 (or its constitutively expressed homologue, hsc70) with amyloid
aggregates protects against amyloid toxicity (31–33). Recombinant hsp70-1A (32) was incubated
ZLWK ȕ2m amyloid fibrils at pH 6.4 in a 1:0.25 or 1:3 molar ratio (monomer equivalent
ȕ2m:chaperone) and the effect of the chaperone on fibril stability was measured using ThT
IOXRUHVFHQFH 7KHVH H[SHULPHQWV VKRZHG WKDW KVS HQKDQFHV WKH NLQHWLF VWDELOLW\ RI ȕ2m fibrils
such that no depolymerisation is observed up to 3 h after dilution to pH 6.4 (Fig. 5C). To determine
ZKHWKHUWKHDGGLWLRQRIKVSDOVRDIIHFWVWKHDELOLW\RIȕ2m fibrils to mediate membrane disruption,
LUVs containing 12 mol% BMP were incubated with fibrils in the presence of hsp70 (Fig. 5D).
These experiments showed that membrane disruption is decreased significantly in the presence of
both 0.25 and 3 molar equivalents of hsp70, in comparison with controls lacking hsp70. The residual
membrane disruption activity is presumably attributed to the activity of the fibrils themselves (Fig.
5A,B (14)). Chemically cross-linking fibrils to enhance their stability also resulted in a significant
decrease in membrane disruption (Fig. S10A-C).
Finally, to determine whether hsp70 is able to protect cells against fibril-induced cellular dysfunction,
SH-SY5Y cells were incubated with either 0.3 µM or 3 µM hsp70 for 6 h prior to adding 1.2 µM
PRQRPHU HTXLYDOHQW FRQFHQWUDWLRQ RI ȕ2P ILEULOV 3UHYLRXV VWXGLHV KDYH VKRZQ WKDW ȕ2m fibrils
inhibit MTT reduction without causing cell death (11). Instead, fibrils disrupt lysosomal function as
evidenced by the inhibition of the degradation of endocytosed ovalbumin (11). Here, hsp70 was
shown to rescue cells from fibril-mediated inhibition of MTT reduction when pre-incubated with 3 µM
KVSSULRUWRWKHDGGLWLRQRIȕ2m fibrils (Fig. 5E). Similarly, the reduction in the capacity of cells to
GHJUDGH RYDOEXPLQ WDNHQ XS E\ HQGRF\WRVLV LQ WKH SUHVHQFH RI ȕ2m fibrils (11) was restored in
hsp70 treated cells (Fig. 5F). Thus, an excess of hsp70 is able to protect against the deleterious
HIIHFWVRIȕ2m fibrils measured by these two assays. Decreasing the extent of fibril depolymerisation
11
by chemical cross-linking also partially rescued the inhibition of MTT reduction by fibrils (Fig. S10D).
Together, these results suggest that the pH-dependent shedding of oligomers from fibrils
FRQWULEXWHV WR ȕ2m fibril-mediated membrane disruption in vitro and to cellular dysfunction, firmly
ascribing the formation of these previously uncharacterised fibril-derived oligomers as facilitators of
amyloid-induced cellular degeneration.
Discussion
Although amyloid fibrils have been shown previously to exhibit dynamic behaviour in solution (6,
34), the importance of such dynamic excursions in the context of biological activity has remained
unclear. Here, by studying amyloid fibril dynamics in solution conditions distinct from those which
promote aggregation and, most importantly, which mimic the cellular environment encountered early
during endocytosis, we show how subtle differences in pH can dramatically influence the repertoire
of species that form over the course of fibril disassembly in vitro. The importance of histidine
UHVLGXHVLQFRQWUROOLQJWKHIDWHRIȕ2m fibril disassembly suggests that other amyloid assemblies may
also display pH-dependent depolymerisation pathways, especially for fibrils that are formed
H[WUDFHOOXODUO\DQGWUDIILFNHGYLDWKHHQGRF\WLFSDWKZD\$VVKRZQKHUHXVLQJȕ2m fibrils formed in
vitro as a model, a change in the pH by just one unit (pH 7.4 to 6.4) dramatically enhances the
potential of fibrils to act as vehicles of cellular dysfunction by enhancing the accumulation of non-
native oligomers able to disrupt membranes in vitro and to contribute to cellular dysfunction.
The endo-lysosomal pathway is emerging as a common route by which extracellular and
LQWUDFHOOXODUDP\ORLGDJJUHJDWHVFDQHOLFLWPHFKDQLVPVRI WR[LFLW\ )RUȕ2m fibrils, cellular
dysfunction is associated with internalisation via endocytosis, with fibril uptake being enhanced for
fibrils of short average length (<400 nm), such as those produced early during fibril formation or via
fibril fragmentation (10). Long-term residence of protease-resistant fibrils within lysosomes leads to
perturbation of the ability of these organelles to degrade endocytosed proteins (11, 25). Moreover,
recent investigations have shown that synthetic membranes containing BMP, a lipid enriched in
HQGRVRPHV DQG O\VRVRPHV  KDYH HQKDQFHG VXVFHSWLELOLW\ WR ȕ2m fibril-mediated membrane
disruption compared with synthetic membranes lacking BMP (13). Together, decreased kinetic
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stability of fibrils under mildly acidic conditions, combined with the specific lipid composition of
HQGRVRPHVO\VRVRPHVFUHDWHVDFHOOXODUHQYLURQPHQWWKDW LVXQLTXHO\VXVFHSWLEOH WRȕ2m amyloid
fibril-mediated cellular damage.
The results presented here also demonstrate that increasing the stability of amyloid fibrils by
chemical cross-linking or the addition of hsp70 leads to decreased membrane disruption and a
reduction in lysosome dysfunction. Hsp70 has been shown to inhibit aggregation and toxicity of a
variety of amyloidogenic systems via distinct mechanisms (31–33). Here we show that hsp70 is able
WR SURWHFW FHOOV DJDLQVW WKH GHOHWHULRXV HIIHFWV RI ȕ2m fibril-mediated cell dysfunction to a greater
extent than chemical cross-linking. This suggests that hsp70 inhibits fibril-mediated cellular
dysfunction by preventing molecular shedding, and potentially through additional mechanisms.
Nevertheless, the results suggest that the pH-induced formation of fibril-derived oligomers is a
VLJQLILFDQWVRXUFHRIȕ2m fibril-mediated cellular dysfunction. pH-induced molecular shedding may
also contribute to fibril-mediated toxicity of other amyloid aggregates that undergo endocytic
WUDIILFNLQJ)RUH[DPSOHWKHVWDELOLVDWLRQRIILEULOVE\VPDOOPROHFXOHVKDVEHHQVKRZQWRUHGXFH$ȕ
WR[LFLW\ E\DFFHOHUDWLQJDVVHPEO\ WRZDUGVȕULFK ILEULOV 2WKHU VWXGLHVKDYHVKRZQ WKDW VPDOO
PROHFXOHV FDQ DOOHYLDWH $ȕ ILEULOPHGLDWHG WR[LFLW\  SUHVXPDEO\ E\ VWDELOLVLQJ ILEULOV DQG
preventing the shedding of toxic species. Further studies using other amyloid systems are now
needed to determine in more detail the role of the endo-lysosomal pathway in modulating
fibril/aggregate stability and hence in contributing to the protection or exacerbation of disease.
By contrast with protein folding reactions which, in most cases, result in the formation of a unique
structural entity (the native state), amyloid formation is a complex kinetic process that can give rise
to fibrils and aggregates with distinct structural, kinetic and/or thermodynamic properties (9, 38). For
example, structurally distinct fibrils of D-synuclein, and those of AE display different biological
activities (9, 39, 40). Depending on their structure, some fibril strains will be less kinetically stable
than others and, thereby, could potentially be more dangerous biologically than their similar, but
PRUHVWDEOHFRXQWHUSDUWV,QDGGLWLRQDVVKRZQKHUHIRUȕ2m, subtle changes in solution conditions
can change the repertoire of oligomers originating from a single fibril strain by altering the energy
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landscape of fibril disassembly. Rather than being the innocuous end products of assembly, fibrils
may thus be a dangerous source of toxic oligomers uniquely formed by molecular shedding in a
mechanism that is dependent on the pH. A better understanding of the link between fibril dynamics,
S+ DQG WR[LFLW\ VXFK DV SUHVHQWHG KHUH IRU ȕ2m fibrils, may provide new avenues for the
development of therapeutic strategies against amyloid disease.
Materials and Methods
More details can be found in SI text.
Protein expression, purification and labelling
:LOGW\SHȕ2m, 151ODEHOOHGȕ2PDQGȕ2m R3C were expressed and purified as previously described
(10, 17, 27). The R3C variant was covalently labelled with maleimide-Alexa488 (Invitrogen)
according to manufacturer’s instructions. Labelled monomer was stored at -80°C in 25 mM sodium
phosphate buffer, pH 7.2. The human hsp70-1A gene was kindly provided by Chris Dobson
(University of Cambridge) and was expressed and purified as described (32).
Fibril formation and kinetic stability assay
)LEULOVDPSOHVZHUHSUHSDUHGE\GLVVROYLQJO\RSKLOLVHGȕ2m monomers in 10 mM sodium phosphate
buffer, pH 2.0 containing 50 mM NaCl. The sample was filtered (0.22 µM Millipore syringe filter) and
the protein concentration adjusted to 120 µM (monomer equivalent concentration). Fibril formation
was seeded using 0.1 % (w/wRISUHIRUPHGȕ2m fibrils as previously described (10). Samples were
then incubated quiescently at room temperature for 48 h. This resulted in fibrils of average length
~1.2 µm measured using AFM, consistent with previous results (10, 13). These fibrils were used for
all subsequent experiments.
7RPRQLWRUWKHVWDELOLW\RIȕ2PILEULOVXSRQFKDQJHVLQS+ȕ2m fibrils (120 µM monomer equivalent
concentration) were diluted 4-fold into 50 mM sodium phosphate buffer, pH 7.4 containing 35 mM
NaCl, or 50 mM sodium phosphate buffer, pH 6.4 containing 85 mM NaCl (ionic strength 164 mM),
previously equilibrated at 25°C and supplemented with 10 µM ThT. ThT fluorescence was
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measured using a BMG Labtech Optima plate reader with excitation and emission band passes of
440 ± 5 nm and 480 ± 5 nm for up to 360 min. ThT fluorescence curves were fitted to a double
exponential function. Errors represent the standard deviation of a minimum of 20 replicates. Soluble
material was also measured as a function of time by SDS PAGE following filtration to separate fibrils
from soluble material (see SI Methods).
NMR
For NMR experiments, depolymerisation of 151ODEHOOHGȕ2m fibrils was initiated by dilution to a final
(monomer equivalent) concentration of 150 PM into the pH 7.4 or pH 6.4 buffers described above.
Each buffer was supplemented with 10% (v/v) D2O and 50 µM ThT (the latter was included to
enable direct comparison with the rates of fibril depolymerisation, measured at the same time using
the same stock of fibrils, by ThT fluorescence). The appearance of NMR-observable species was
then monitored over time by acquiring SOFAST 1H-15N HSQC spectra (41) at 25qC using a Varian
Inova spectrometer (Agilent) at a 1H frequency of 750MHz, equipped with a cryogenic probe. The
dead time of the experiment was 3-7 min and the acquisition time of individual spectra varied
between 5 – 10 min (4 and 8 scans per incremental delay, respectively). At least 20 sequential 1H-
15N HSQC spectra were acquired with a final acquisition (of 100% native monomer) performed 24 h
after the initial dilution. The experiment was repeated several times, increasing the spectral
acquisition time to optimise the signal-to-noise ratio, while maintaining time resolution. The average
of two such experiments is shown in Figure 2. The error bars represent the propagated error of the
fits to single exponentials for each residue over the two experiments.
FCS
Details of the instrument set-up, data collection and analysis can be found in SI text.
Hsp70 binding and cell assays
7KHNLQHWLFVWDELOLW\RIȕ2m amyloid fibrils in the presence of hsp70 was monitored by diluting fibrils
formed at pH 2.0 to 12 µM (monomer equivalent concentration) in pH 6.4 buffer to which 0, 0.25 or
3 molar equivalents of recombinant hsp70-1A or 3 molar equivalents of BSA were added.
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Depolymerisation was then monitored at 25°C by ThT fluorescence as outlined above. Data shown
are the average from a minimum of three independent replicates.
MTT and lysosome proteolysis assays were performed on SH-SY5Y cells as previously described
(11). Cells were cultured in the presence of 0, 0.3 or 3.0 PM hsp70 for 6 h prior to the addition of 1.2
µM (monomer equivalent concentration) of fibrils that had been fragmented for 48 h as previously
GHVFULEHG  1DWLYH ȕ2m monomer, buffer-only, hsp70-only, or 0.1% (w/v) sodium azide were
added as controls. For the MTT assay, cells were incubated for a further 24 h prior to the addition of
20 µl 5mg.ml-1 MTT. After further incubation for 60 min the media was removed and the resulting
formazan crystals were solubilised in 100% dimethyl sulfoxide. Reduction of MTT was quantified by
measuring the absorbance at 570 nm and subtracting background light scattering at 650 nm. The
error bars represent the standard deviation from three independent experiments, each containing
five replicates. Details of the lysosome proteolysis assay can be found in SI Methods.
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Figure Legends
Figure 1. pH dependence of fibril disassembly. E2m amyloid fibrils formed at pH 2.0 were diluted
into (A) pH 7.4 or (B) pH 6.4 buffer and disassembly monitored by ThT fluorescence (solid lines
show a fit to a double exponential). Soluble material released as fibril depolymerisation proceeds
was isolated using a filter-trap assay, resolved by SDS-PAGE (inset), and quantified by
densitometry of the gel (dashed line).
)LJXUH7KHIRUPDWLRQRIQDWLYHȕ2m monomers during fibril depolymerisation monitored by
real-time NMR. (A) Select regions of 1H-15N HSQC spectra collected at different times during
depolymerisation of 151ODEHOOHG ȕ2m fibrils at pH 7.4 (purple) or pH 6.4 (green). Residue
assignments are shown on the bottom panels. (B) The peak intensity of residue 19K versus time
during fibril depolymerisation at pH 7.4 (purple) or pH 6.4 (green). The data are fitted to single
exponential functions (solid lines). Coloured bars highlight the time-points at which the spectra
shown in (A) were acquired (framed in the same colour). (C) Time constants (W) of appearance of
native resonances during fibril depolymerisation at pH 7.4 or (D) pH 6.4. Black dashed lines indicate
the average under each condition. Red dashed lines depict W of ThT fluorescence decay calculated
in Fig. 1A,B.
Figure 3. pH dependent formation of oligomers during fibril disassembly. (A) Apparent RH
distributions of soluble species extracted from autocorrelation curves collected by FCS and
analysed by MEM at different times during E2m fibril disassembly at pH 7.4 or pH 6.4. The apparent
RH values shown are the peak centre of each ensemble. Negative stain TEM image of fibrils 30 min
or 60 min after the initiation of fibril depolymerisation at (B) pH 7.4 or (C) pH 6.4 (scale bar = 150
nm). (D) Cryo-EM class averages of oligomers released from fibrils at pH 6.4, 5 min after initiating
disassembly. Each box is 60 x 60 nm (see also Fig. S9). (E) Histogram showing size distribution of
the particles used to compute the class averages in (D).
Figure 4. Structural analysis of soluble material formed during fibril disassembly. (A) Dot
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blots of insoluble and soluble material (filtrate) generated 30 min or 60 min after the initiation of fibril
disassembly at pH 7.4 or pH 6.4, respectively. Samples were immunoblotted with anti-fibril (W01
RUDQWLȕ2PDQWLERGLHV6,0HWKRGV&RQWUROEORWVDUHRIȕ2m fibrils at pH 2.0. Mean residue
ellipticity of the filtrate isolated as stated above at (B) pH 7.4 or (C) pH 6.4 measured using far-UV
&'6SHFWUDRI QDWLYHȕ2m (blue) were acquired at the same protein concentration (SI Methods).
Difference spectra are shown in dashed lines. ANS fluorescence emission spectra of the filtrate
LVRODWHGDVVWDWHGDERYHDW'S+RU(S+DQGRIQDWLYHȕ2m at equivalent concentrations.
&XUYHVDUHQRUPDOLVHGWRWKHPD[LPXPDPSOLWXGHRIWKHVSHFWUXPRIDFLGXQIROGHGȕ2m at pH 2.0
JUH\ GDVKHG OLQH DFTXLUHG DW WKH VDPH SURWHLQ FRQFHQWUDWLRQ ,Q &( QDWLYH ȕ2m monomer
controls are shown in cyan.
Figure 5. Fibril-derived oligomers cause membrane disruption and cellular dysfunction. (A)
Membrane disruption of total protein (fibrils + soluble material) versus soluble material (filtrate)
isolated 60 min after the initiation of fibril disassembly at pH 6.4 measured using a
carboxyfluorescein dye release assay (SI Methods). The dye release of the equivalent
concentration (to total protein sample) of native monomers was also measured (native E2m). (B)
Normalised dye release efficiency per µM of protein (determined using SDS-PAGE densitometry).
The fibril concentration was calculated as the amount of non-filtrated material present 60 min after
the onset of fibril disassembly. (C) Kinetic stability of E2m fibrils (12 µM monomer equivalent
concentration) at pH 6.4 measured using ThT fluorescence in the presence or absence (black
dashed) of 0.25 molar (orange) or 3 molar (green) equivalents of hsp70. A control in the presence of
a 3-fold molar excess of bovine serum albumin (BSA) is also shown (grey). (D) Membrane
GLVUXSWLRQE\ȕ2m fibrils 30 min after the initiation of fibril disassembly as measured by dye release
in the presence of 0.25 or 3 molar equivalents of hsp70. (E) The reduction of MTT in the presence
RI0ȕ2m amyloid fibrils with or without the addition of 0.25 or 3 molar equivalents of hsp70.
MTT reduction is expressed as a percentage in comparison with cells incubated with hsp70 in the
DEVHQFH RI ILEULOV ) 6+6<< FHOOV ZHUH LQFXEDWHG ZLWK EXIIHU  ȝ0 PRQRPHU HTXLYDOHQW
FRQFHQWUDWLRQ QDWLYH ȕ2m monomers or fibril samples after pre-incubation in the presence (light
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grey) or absence (dark grey) of a 3-fold molar excess of hsp70. The lysosomal degradation of
endocytosed Alexa647-labelled ovalbumin was quantified by flow cytometry (11). * represents a p
value of <0.05.





